Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver

Serum small dense LDL-cholesterol (sdLDL-C) levels in healthy controls and the cases with diabetes (T2DM) and metabolic syndrome (MetS) with or without a fatty liver in a large, typical Japanese population was determined. The plasma lipids and lipoproteins, including sdLDL-C by homogeneous assay, we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinica chimica acta 2015-01, Vol.438, p.70-79
Hauptverfasser: Kikkawa, Koji, Nakajima, Katsuyuki, Shimomura, Younosuke, Tokita, Yoshiharu, Machida, Tetsuo, Sumino, Hiroyuki, Murakami, Masami
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 79
container_issue
container_start_page 70
container_title Clinica chimica acta
container_volume 438
creator Kikkawa, Koji
Nakajima, Katsuyuki
Shimomura, Younosuke
Tokita, Yoshiharu
Machida, Tetsuo
Sumino, Hiroyuki
Murakami, Masami
description Serum small dense LDL-cholesterol (sdLDL-C) levels in healthy controls and the cases with diabetes (T2DM) and metabolic syndrome (MetS) with or without a fatty liver in a large, typical Japanese population was determined. The plasma lipids and lipoproteins, including sdLDL-C by homogeneous assay, were determined in controls, MetS and T2DM patients (n=5255). The cases with MetS and preliminary MetS (pre-MetS) as well as T2DM and preliminary T2DM (pre-DM) were selected based on the Japanese criteria for MetS and T2DM. Fatty liver was diagnosed using the ultrasonography. The 75th percentile values for sdLDL-C were 27.5mg/dl for men and 23.3mg/dl for women and increased with age. The concentrations of sdLDL-C and sdLDL-C/LDL-C were significantly higher in pre-MetS and pre-T2DM patients than healthy controls as well as in MetS and T2DM patients. Significantly higher sdLDL-C was found in cases with a fatty liver than without a fatty liver in all five groups. Significantly elevated sdLDL-C levels were found in pre-MetS, MetS and pre-T2DM, T2DM patients compared to the healthy controls. Fatty liver significantly enhanced serum sdLDL-C levels and the multiple regression analyses ascertained that fatty liver was an independent determinant for sdLDL-C. •The normal range of sdLDL-C in Japanese population was determined.•sdLDL-C was significantly higher in pre-MetS and pre-T2DM than in controls.•sdLDL-C was highest in MetS and T2DM when associated with a fatty liver.
doi_str_mv 10.1016/j.cca.2014.07.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1629961951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009898114003040</els_id><sourcerecordid>1629961951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-dbe9362cdb0b30618a2c0a6a0bbcbf2c6c3af4bab2f462f7451ad9cffcb42ce63</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EokPhAdggL1mQYDv_YoVafjVSF4W1dW3fEI-ceLCdVnkZnhW3U1h2dWXpfEc6_gh5zVnJGW_fH0qtoRSM1yXrSsa7J2TH-64qqnoQT8mOMTYU_dDzM_IixkN-1qzlz8mZaFjDesZ25M_1DM5Rg0tEur_cUz15hzFh8I7OCHENaKja6ORn_wsX9GukECNs1C70OxxhwUxOCC5NG9V-SZmM7zKbQHlnNY3bYoKfkcJiqLGgMGGkR0gWlxTprU0T9eH--jVRoCOktFFnbzC8JM9GcBFfPdxz8vPzpx8XX4v91ZdvFx_3ha6aKhVG4VC1QhvFVJUn9iA0gxaYUlqNQre6grFWoMRYt2Ls6oaDGfQ4alULjW11Tt6eeo_B_17zfjnbqNE5uF8seSuGoeVDw3OUn6I6-BgDjvIY7Axhk5zJOy3yILMWeadFsk5mLZl581C_qhnNf-Kfhxz4cApgHnljMcio8_doNDagTtJ4-0j9X8nAokc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1629961951</pqid></control><display><type>article</type><title>Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kikkawa, Koji ; Nakajima, Katsuyuki ; Shimomura, Younosuke ; Tokita, Yoshiharu ; Machida, Tetsuo ; Sumino, Hiroyuki ; Murakami, Masami</creator><creatorcontrib>Kikkawa, Koji ; Nakajima, Katsuyuki ; Shimomura, Younosuke ; Tokita, Yoshiharu ; Machida, Tetsuo ; Sumino, Hiroyuki ; Murakami, Masami</creatorcontrib><description>Serum small dense LDL-cholesterol (sdLDL-C) levels in healthy controls and the cases with diabetes (T2DM) and metabolic syndrome (MetS) with or without a fatty liver in a large, typical Japanese population was determined. The plasma lipids and lipoproteins, including sdLDL-C by homogeneous assay, were determined in controls, MetS and T2DM patients (n=5255). The cases with MetS and preliminary MetS (pre-MetS) as well as T2DM and preliminary T2DM (pre-DM) were selected based on the Japanese criteria for MetS and T2DM. Fatty liver was diagnosed using the ultrasonography. The 75th percentile values for sdLDL-C were 27.5mg/dl for men and 23.3mg/dl for women and increased with age. The concentrations of sdLDL-C and sdLDL-C/LDL-C were significantly higher in pre-MetS and pre-T2DM patients than healthy controls as well as in MetS and T2DM patients. Significantly higher sdLDL-C was found in cases with a fatty liver than without a fatty liver in all five groups. Significantly elevated sdLDL-C levels were found in pre-MetS, MetS and pre-T2DM, T2DM patients compared to the healthy controls. Fatty liver significantly enhanced serum sdLDL-C levels and the multiple regression analyses ascertained that fatty liver was an independent determinant for sdLDL-C. •The normal range of sdLDL-C in Japanese population was determined.•sdLDL-C was significantly higher in pre-MetS and pre-T2DM than in controls.•sdLDL-C was highest in MetS and T2DM when associated with a fatty liver.</description><identifier>ISSN: 0009-8981</identifier><identifier>EISSN: 1873-3492</identifier><identifier>DOI: 10.1016/j.cca.2014.07.017</identifier><identifier>PMID: 25050800</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Cholesterol, LDL - blood ; Coronary heart disease (CHD) ; Diabetes Complications - blood ; Fatty Liver ; Fatty Liver - blood ; Fatty Liver - complications ; Female ; Homogeneous sdLDL-C assay ; Humans ; Japan ; Male ; Metabolic Syndrome - blood ; Metabolic Syndrome - complications ; MetS ; Middle Aged ; Preliminary-metabolic syndrome (pre-MetS) ; Preliminary-type 2 diabetes mellitus (pre-T2DM) ; T2DM</subject><ispartof>Clinica chimica acta, 2015-01, Vol.438, p.70-79</ispartof><rights>2014</rights><rights>Copyright © 2014. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-dbe9362cdb0b30618a2c0a6a0bbcbf2c6c3af4bab2f462f7451ad9cffcb42ce63</citedby><cites>FETCH-LOGICAL-c353t-dbe9362cdb0b30618a2c0a6a0bbcbf2c6c3af4bab2f462f7451ad9cffcb42ce63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0009898114003040$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25050800$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kikkawa, Koji</creatorcontrib><creatorcontrib>Nakajima, Katsuyuki</creatorcontrib><creatorcontrib>Shimomura, Younosuke</creatorcontrib><creatorcontrib>Tokita, Yoshiharu</creatorcontrib><creatorcontrib>Machida, Tetsuo</creatorcontrib><creatorcontrib>Sumino, Hiroyuki</creatorcontrib><creatorcontrib>Murakami, Masami</creatorcontrib><title>Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver</title><title>Clinica chimica acta</title><addtitle>Clin Chim Acta</addtitle><description>Serum small dense LDL-cholesterol (sdLDL-C) levels in healthy controls and the cases with diabetes (T2DM) and metabolic syndrome (MetS) with or without a fatty liver in a large, typical Japanese population was determined. The plasma lipids and lipoproteins, including sdLDL-C by homogeneous assay, were determined in controls, MetS and T2DM patients (n=5255). The cases with MetS and preliminary MetS (pre-MetS) as well as T2DM and preliminary T2DM (pre-DM) were selected based on the Japanese criteria for MetS and T2DM. Fatty liver was diagnosed using the ultrasonography. The 75th percentile values for sdLDL-C were 27.5mg/dl for men and 23.3mg/dl for women and increased with age. The concentrations of sdLDL-C and sdLDL-C/LDL-C were significantly higher in pre-MetS and pre-T2DM patients than healthy controls as well as in MetS and T2DM patients. Significantly higher sdLDL-C was found in cases with a fatty liver than without a fatty liver in all five groups. Significantly elevated sdLDL-C levels were found in pre-MetS, MetS and pre-T2DM, T2DM patients compared to the healthy controls. Fatty liver significantly enhanced serum sdLDL-C levels and the multiple regression analyses ascertained that fatty liver was an independent determinant for sdLDL-C. •The normal range of sdLDL-C in Japanese population was determined.•sdLDL-C was significantly higher in pre-MetS and pre-T2DM than in controls.•sdLDL-C was highest in MetS and T2DM when associated with a fatty liver.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Case-Control Studies</subject><subject>Cholesterol, LDL - blood</subject><subject>Coronary heart disease (CHD)</subject><subject>Diabetes Complications - blood</subject><subject>Fatty Liver</subject><subject>Fatty Liver - blood</subject><subject>Fatty Liver - complications</subject><subject>Female</subject><subject>Homogeneous sdLDL-C assay</subject><subject>Humans</subject><subject>Japan</subject><subject>Male</subject><subject>Metabolic Syndrome - blood</subject><subject>Metabolic Syndrome - complications</subject><subject>MetS</subject><subject>Middle Aged</subject><subject>Preliminary-metabolic syndrome (pre-MetS)</subject><subject>Preliminary-type 2 diabetes mellitus (pre-T2DM)</subject><subject>T2DM</subject><issn>0009-8981</issn><issn>1873-3492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhS0EokPhAdggL1mQYDv_YoVafjVSF4W1dW3fEI-ceLCdVnkZnhW3U1h2dWXpfEc6_gh5zVnJGW_fH0qtoRSM1yXrSsa7J2TH-64qqnoQT8mOMTYU_dDzM_IixkN-1qzlz8mZaFjDesZ25M_1DM5Rg0tEur_cUz15hzFh8I7OCHENaKja6ORn_wsX9GukECNs1C70OxxhwUxOCC5NG9V-SZmM7zKbQHlnNY3bYoKfkcJiqLGgMGGkR0gWlxTprU0T9eH--jVRoCOktFFnbzC8JM9GcBFfPdxz8vPzpx8XX4v91ZdvFx_3ha6aKhVG4VC1QhvFVJUn9iA0gxaYUlqNQre6grFWoMRYt2Ls6oaDGfQ4alULjW11Tt6eeo_B_17zfjnbqNE5uF8seSuGoeVDw3OUn6I6-BgDjvIY7Axhk5zJOy3yILMWeadFsk5mLZl581C_qhnNf-Kfhxz4cApgHnljMcio8_doNDagTtJ4-0j9X8nAokc</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Kikkawa, Koji</creator><creator>Nakajima, Katsuyuki</creator><creator>Shimomura, Younosuke</creator><creator>Tokita, Yoshiharu</creator><creator>Machida, Tetsuo</creator><creator>Sumino, Hiroyuki</creator><creator>Murakami, Masami</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150101</creationdate><title>Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver</title><author>Kikkawa, Koji ; Nakajima, Katsuyuki ; Shimomura, Younosuke ; Tokita, Yoshiharu ; Machida, Tetsuo ; Sumino, Hiroyuki ; Murakami, Masami</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-dbe9362cdb0b30618a2c0a6a0bbcbf2c6c3af4bab2f462f7451ad9cffcb42ce63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Case-Control Studies</topic><topic>Cholesterol, LDL - blood</topic><topic>Coronary heart disease (CHD)</topic><topic>Diabetes Complications - blood</topic><topic>Fatty Liver</topic><topic>Fatty Liver - blood</topic><topic>Fatty Liver - complications</topic><topic>Female</topic><topic>Homogeneous sdLDL-C assay</topic><topic>Humans</topic><topic>Japan</topic><topic>Male</topic><topic>Metabolic Syndrome - blood</topic><topic>Metabolic Syndrome - complications</topic><topic>MetS</topic><topic>Middle Aged</topic><topic>Preliminary-metabolic syndrome (pre-MetS)</topic><topic>Preliminary-type 2 diabetes mellitus (pre-T2DM)</topic><topic>T2DM</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kikkawa, Koji</creatorcontrib><creatorcontrib>Nakajima, Katsuyuki</creatorcontrib><creatorcontrib>Shimomura, Younosuke</creatorcontrib><creatorcontrib>Tokita, Yoshiharu</creatorcontrib><creatorcontrib>Machida, Tetsuo</creatorcontrib><creatorcontrib>Sumino, Hiroyuki</creatorcontrib><creatorcontrib>Murakami, Masami</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinica chimica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kikkawa, Koji</au><au>Nakajima, Katsuyuki</au><au>Shimomura, Younosuke</au><au>Tokita, Yoshiharu</au><au>Machida, Tetsuo</au><au>Sumino, Hiroyuki</au><au>Murakami, Masami</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver</atitle><jtitle>Clinica chimica acta</jtitle><addtitle>Clin Chim Acta</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>438</volume><spage>70</spage><epage>79</epage><pages>70-79</pages><issn>0009-8981</issn><eissn>1873-3492</eissn><abstract>Serum small dense LDL-cholesterol (sdLDL-C) levels in healthy controls and the cases with diabetes (T2DM) and metabolic syndrome (MetS) with or without a fatty liver in a large, typical Japanese population was determined. The plasma lipids and lipoproteins, including sdLDL-C by homogeneous assay, were determined in controls, MetS and T2DM patients (n=5255). The cases with MetS and preliminary MetS (pre-MetS) as well as T2DM and preliminary T2DM (pre-DM) were selected based on the Japanese criteria for MetS and T2DM. Fatty liver was diagnosed using the ultrasonography. The 75th percentile values for sdLDL-C were 27.5mg/dl for men and 23.3mg/dl for women and increased with age. The concentrations of sdLDL-C and sdLDL-C/LDL-C were significantly higher in pre-MetS and pre-T2DM patients than healthy controls as well as in MetS and T2DM patients. Significantly higher sdLDL-C was found in cases with a fatty liver than without a fatty liver in all five groups. Significantly elevated sdLDL-C levels were found in pre-MetS, MetS and pre-T2DM, T2DM patients compared to the healthy controls. Fatty liver significantly enhanced serum sdLDL-C levels and the multiple regression analyses ascertained that fatty liver was an independent determinant for sdLDL-C. •The normal range of sdLDL-C in Japanese population was determined.•sdLDL-C was significantly higher in pre-MetS and pre-T2DM than in controls.•sdLDL-C was highest in MetS and T2DM when associated with a fatty liver.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>25050800</pmid><doi>10.1016/j.cca.2014.07.017</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-8981
ispartof Clinica chimica acta, 2015-01, Vol.438, p.70-79
issn 0009-8981
1873-3492
language eng
recordid cdi_proquest_miscellaneous_1629961951
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Aged
Aged, 80 and over
Case-Control Studies
Cholesterol, LDL - blood
Coronary heart disease (CHD)
Diabetes Complications - blood
Fatty Liver
Fatty Liver - blood
Fatty Liver - complications
Female
Homogeneous sdLDL-C assay
Humans
Japan
Male
Metabolic Syndrome - blood
Metabolic Syndrome - complications
MetS
Middle Aged
Preliminary-metabolic syndrome (pre-MetS)
Preliminary-type 2 diabetes mellitus (pre-T2DM)
T2DM
title Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T15%3A22%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Small%20dense%20LDL%20cholesterol%20measured%20by%20homogeneous%20assay%20in%20Japanese%20healthy%20controls,%20metabolic%20syndrome%20and%20diabetes%20patients%20with%20or%20without%20a%20fatty%20liver&rft.jtitle=Clinica%20chimica%20acta&rft.au=Kikkawa,%20Koji&rft.date=2015-01-01&rft.volume=438&rft.spage=70&rft.epage=79&rft.pages=70-79&rft.issn=0009-8981&rft.eissn=1873-3492&rft_id=info:doi/10.1016/j.cca.2014.07.017&rft_dat=%3Cproquest_cross%3E1629961951%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1629961951&rft_id=info:pmid/25050800&rft_els_id=S0009898114003040&rfr_iscdi=true